Ben-Hua Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Ben-Hua Wu has a total of 36 co-authors. Here are the top co-authors by number of shared publications:
- De-Feng Li
Department of Gastroenterology, Shenzhen People’s Hospital, The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong, China
5 shared publications Li-Sheng Wang
Department of Gastroenterology, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong Province, China
5 shared publications- Li-Sheng Wang
Department of Gastroenterology, Shenzhen People’s Hospital (The Second Clinical Medical College, Jinan University; The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, 518020, People’s Republic of China
5 shared publications - Jun Yao
Department of Gastroenterology, Shenzhen People’s Hospital, The Second Clinical Medical College, Jinan University, Shenzhen, Guangdong, China
4 shared publications - Cheng Wei
Department of Gastroenterology, Shenzhen People's Hospital (The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology), Shenzhen, Guangdong, China
3 shared publications - Feng Xiong
Department of Gastroenterology, Shenzhen People’s Hospital, The Second Clinical Medical College, Jinan University, The First Affiliated Hospital, Southern University of Science and Technology, Shenzhen 518020, Guangdong, China
3 shared publications
Latest Publications
Endoscopic mucosal and submucosal cutting for long benign oesophageal strictures
Benign oesophageal strictures, particularly long-segment ones, present major clinical challenges—especially when caused by complex factors such as corrosive injury, radiation, postablation or mucosal resection, surgery or pill-induced damage.1 2 These strictures are typically ≥2 cm, tortuous, multifocal and often inaccessible using standard endoscopic tools. Management usually involves dilation (sometimes extended to self-dilation) and incision or avulsion techniques.3–5 While these offer short-term relief with success rates up to 94%, restenosis is common—reported in up to 62.3%—leading to frequent interventions and reduced patient compliance.6 Endoscopic incision therapies, including radial incision and cutting and endoscopic incision therapy (EIT), show somewhat lower recurrence rates (53.5%–75%) but are associated with higher complication risks, such as perforation, and require advanced technical skills.7–9 Inspired by the success of peroral endoscopic myotomy (POEM) for achalasia,10 we developed a novel technique involving dissection through the mucosa and submucosa down to the muscularis propria.
Endoscopic mucosal and submucosal cutting for long benign oesophageal strictures
Benign oesophageal strictures, particularly long-segment ones, present major clinical challenges—especially when caused by complex factors such as corrosive injury, radiation, postablation or mucosal resection, surgery or pill-induced damage.1 2 These strictures are typically ≥2 cm, tortuous, multifocal and often inaccessible using standard endoscopic tools. Management usually involves dilation (sometimes extended to self-dilation) and incision or avulsion techniques.3–5 While these offer short-term relief with success rates up to 94%, restenosis is common—reported in up to 62.3%—leading to frequent interventions and reduced patient compliance.6 Endoscopic incision therapies, including radial incision and cutting and endoscopic incision therapy (EIT), show somewhat lower recurrence rates (53.5%–75%) but are associated with higher complication risks, such as perforation, and require advanced technical skills.7–9 Inspired by the success of peroral endoscopic myotomy (POEM) for achalasia,10 we developed a novel technique involving dissection through the mucosa and submucosa down to the muscularis propria.
- Open Access
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E1427-E1429
Stalk-directed endoscopic submucosal dissection for a giant Brunnerʼs gland gamartoma causing duodenal intussusception with defect closure using three-arm traction clips
A 31-year-old man presented with 6 days of hematemesis and melena. Outside gastroscopy suggested duodenal intussusception with multiple ulcers. Contrast-enhanced computed tomography showed a pedunculated mass arising from the duodenal bulb and prolapsing into the second and third portions of the duodenum, consistent with intussusception ([Fig. 1]). Endoscopic ultrasound confirmed a bulb-originating lesion with a thick stalk intermittently telescoping into the distal duodenum; mucosal biopsies indicated Brunner’s gland hyperplasia. Endoscopic resection was planned. During therapeutic endoscopy, the lesion was large and highly mobile, precluding secure Endoloop placement because the nylon loop could not be advanced around the mass to the stalk base [1]. A stalk-directed endoscopic submucosal dissection (ESD) strategy was therefore adopted [2]. After the submucosal lift at the stalk, a mucosal incision was made, followed by stepwise dissection. The thick stalk incorporated muscularis propria, necessitating deliberate exposure and division of this layer under direct visualization to achieve complete transection. Final resection was performed with an IT2 knife, and the specimen was retrieved en bloc ([Fig. 2]). Inspection of the resection bed revealed a focal muscularis propria defect with preserved serosa. Closure was initiated with a three-arm clip (Nanjing Micro-Tech) for precise edge apposition, followed by sequential deployment of multiple through-the-scope clips to ensure complete apposition and reinforcement ([Video 1]). The procedure was uneventful. Liquids were started on postoperative day 2, and the patient was discharged on day 3. At 1-month follow-up, he remained asymptomatic. Histopathology of the 6.0 cm × 4.5 cm × 2.0 cm specimen confirmed a duodenal hamartomatous polyp consistent with Brunner’s gland hamartoma ([Fig. 3]). This case highlights that stalk-directed ESD can safely resect giant, intussuscepting Brunner’s gland hamartomas, and that three-arm clip traction plus multi-clip closure can secure a muscularis defect in the thin-walled duodenum, potentially reducing delayed bleeding and perforation. Endoscopy_UCTN_Code_TTT_1AQ_2AD_3AD Article published online: 08 December 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E1427-E1429
Open AccessStalk-directed endoscopic submucosal dissection for a giant Brunnerʼs gland gamartoma causing duodenal intussusception with defect closure using three-arm traction clips
A 31-year-old man presented with 6 days of hematemesis and melena. Outside gastroscopy suggested duodenal intussusception with multiple ulcers. Contrast-enhanced computed tomography showed a pedunculated mass arising from the duodenal bulb and prolapsing into the second and third portions of the duodenum, consistent with intussusception ([Fig. 1]). Endoscopic ultrasound confirmed a bulb-originating lesion with a thick stalk intermittently telescoping into the distal duodenum; mucosal biopsies indicated Brunner’s gland hyperplasia. Endoscopic resection was planned. During therapeutic endoscopy, the lesion was large and highly mobile, precluding secure Endoloop placement because the nylon loop could not be advanced around the mass to the stalk base [1]. A stalk-directed endoscopic submucosal dissection (ESD) strategy was therefore adopted [2]. After the submucosal lift at the stalk, a mucosal incision was made, followed by stepwise dissection. The thick stalk incorporated muscularis propria, necessitating deliberate exposure and division of this layer under direct visualization to achieve complete transection. Final resection was performed with an IT2 knife, and the specimen was retrieved en bloc ([Fig. 2]). Inspection of the resection bed revealed a focal muscularis propria defect with preserved serosa. Closure was initiated with a three-arm clip (Nanjing Micro-Tech) for precise edge apposition, followed by sequential deployment of multiple through-the-scope clips to ensure complete apposition and reinforcement ([Video 1]). The procedure was uneventful. Liquids were started on postoperative day 2, and the patient was discharged on day 3. At 1-month follow-up, he remained asymptomatic. Histopathology of the 6.0 cm × 4.5 cm × 2.0 cm specimen confirmed a duodenal hamartomatous polyp consistent with Brunner’s gland hamartoma ([Fig. 3]). This case highlights that stalk-directed ESD can safely resect giant, intussuscepting Brunner’s gland hamartomas, and that three-arm clip traction plus multi-clip closure can secure a muscularis defect in the thin-walled duodenum, potentially reducing delayed bleeding and perforation. Endoscopy_UCTN_Code_TTT_1AQ_2AD_3AD Article published online: 08 December 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E1222-E1223
A rare cause of partial small bowel obstruction
A 59-year-old man presented with a five-month history of recurrent abdominal pain and vomiting. Five months prior to admission, during an episode of abdominal pain, an abdominal computed tomography (CT) revealed segmental wall thickening and blurring of the small bowel wall in the right mid-abdomen, with obscuration of the adjacent mesenteric fat planes. Mild upstream small bowel dilatation with fecalized content and mural blurring suggested partial small bowel obstruction ([Fig. 1]). He was managed conservatively at a local hospital with fasting, intravenous fluids, and antibiotic therapy, which resulted in symptomatic improvement. However, he subsequently experienced two milder episodes of abdominal pain, neither of which received a medical evaluation. On admission, a physical examination revealed a soft, non-distended, and non-tender abdomen. Laboratory investigations revealed a normal white blood cell count (6.87 × 10^9/L) with mild eosinophilia (14.3%). No abnormalities were found in other blood biochemical tests. Upper gastrointestinal endoscopy revealed a nonspecific gastroduodenal inflammation. Random colonoscopic biopsy results were unremarkable. During oral double-balloon enteroscopy, advancement to approximately 300 cm into the ileum revealed a segment of markedly edematous and hyperemic small-bowel mucosa ([Fig. 2] a). An actively motile live worm surrounded by congested and edematous mucosa with mild hemorrhage was observed penetrating the intestinal mucosa ([Fig. 2] b). The helminth was successfully extracted using the biopsy forceps ([Fig. 2] c, [Video 1]). Histopathological analysis confirmed that the specimen was Enterobius vermicularis ([Fig. 3] a–c). Based on this, the patient was clearly diagnosed with partial small bowel obstruction caused by enterobiasis of the small intestine. The patient underwent a course of albendazole, an anthelmintic agent effective against Enterobius vermicularis. Following antiparasitic therapy, the patient achieved complete resolution of symptoms, with no further episodes of abdominal pain or vomiting. Small bowel involvement by Enterobius vermicularis is exceptionally rare, particularly when it presents as a mechanical intestinal obstruction. In this case, the diagnosis was established through enteroscopy, which directly visualized a live worm traversing the inflamed mucosa of the ileal segment. Previous reports have documented small bowel obstruction secondary to parasitic infections such as Schistosoma-associated Meckel’s diverticulitis [1] and nematode infestation [2], both of which were diagnosed intraoperatively through laparoscopy or laparotomy. In contrast, our case highlights the role of deep enteroscopy as a minimally invasive diagnostic and therapeutic modality, representing a rare instance of small bowel obstruction caused by Enterobius vermicularis infection that was successfully managed without surgical intervention. Endoscopy_UCTN_Code_CCL_1AB_2AZ_3AZ Article published online: 05 November 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E1222-E1223
Open AccessA rare cause of partial small bowel obstruction
A 59-year-old man presented with a five-month history of recurrent abdominal pain and vomiting. Five months prior to admission, during an episode of abdominal pain, an abdominal computed tomography (CT) revealed segmental wall thickening and blurring of the small bowel wall in the right mid-abdomen, with obscuration of the adjacent mesenteric fat planes. Mild upstream small bowel dilatation with fecalized content and mural blurring suggested partial small bowel obstruction ([Fig. 1]). He was managed conservatively at a local hospital with fasting, intravenous fluids, and antibiotic therapy, which resulted in symptomatic improvement. However, he subsequently experienced two milder episodes of abdominal pain, neither of which received a medical evaluation. On admission, a physical examination revealed a soft, non-distended, and non-tender abdomen. Laboratory investigations revealed a normal white blood cell count (6.87 × 10^9/L) with mild eosinophilia (14.3%). No abnormalities were found in other blood biochemical tests. Upper gastrointestinal endoscopy revealed a nonspecific gastroduodenal inflammation. Random colonoscopic biopsy results were unremarkable. During oral double-balloon enteroscopy, advancement to approximately 300 cm into the ileum revealed a segment of markedly edematous and hyperemic small-bowel mucosa ([Fig. 2] a). An actively motile live worm surrounded by congested and edematous mucosa with mild hemorrhage was observed penetrating the intestinal mucosa ([Fig. 2] b). The helminth was successfully extracted using the biopsy forceps ([Fig. 2] c, [Video 1]). Histopathological analysis confirmed that the specimen was Enterobius vermicularis ([Fig. 3] a–c). Based on this, the patient was clearly diagnosed with partial small bowel obstruction caused by enterobiasis of the small intestine. The patient underwent a course of albendazole, an anthelmintic agent effective against Enterobius vermicularis. Following antiparasitic therapy, the patient achieved complete resolution of symptoms, with no further episodes of abdominal pain or vomiting. Small bowel involvement by Enterobius vermicularis is exceptionally rare, particularly when it presents as a mechanical intestinal obstruction. In this case, the diagnosis was established through enteroscopy, which directly visualized a live worm traversing the inflamed mucosa of the ileal segment. Previous reports have documented small bowel obstruction secondary to parasitic infections such as Schistosoma-associated Meckel’s diverticulitis [1] and nematode infestation [2], both of which were diagnosed intraoperatively through laparoscopy or laparotomy. In contrast, our case highlights the role of deep enteroscopy as a minimally invasive diagnostic and therapeutic modality, representing a rare instance of small bowel obstruction caused by Enterobius vermicularis infection that was successfully managed without surgical intervention. Endoscopy_UCTN_Code_CCL_1AB_2AZ_3AZ Article published online: 05 November 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- Open Access
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E453-E454
A rare etiology of partial intestinal obstruction and sepsis: idiopathic mesenteric phlebosclerosis
A 64-year-old woman presented with abdominal pain and vomiting for 4 days. She had a medical history of long-term use of traditional Chinese medicine prescribed by her family doctor for more than 10 years. Blood biochemistry tests showed an increase in leukocytosis (WBC 17.18 × 109/L, 88% neutrophils) and elevated procalcitonin (76.42 ng/mL), indicating a systemic infection. Notably, noncontrast abdominal CT revealed signs of incomplete bowel obstruction, especially characteristic mesenteric vessel calcification and colonic wall thickening in the cecum ([Fig. 1]). After empirical treatment with broad-spectrum antibiotics (ertapenem and teicoplanin) for suspected sepsis, the patient’s condition improved, procalcitonin levels returned to normal, and the gastrointestinal function was restored. We then performed a routine colonoscopy and found that the confined colonic mucosa had a dark-purple discoloration, similar to widespread varicosities. When the colon is fully inflated, normal mucosa between the dark purple areas corresponding to the submucosal veins could be observed, which, combined with the patient's previous medication history, clinical manifestations, abdominal CT, and colonoscopy, the patient can be clearly diagnosed with IMP ([Fig. 2], [Video 1]). After conservative treatment, the patientʼs abdominal pain and vomiting resolved and she tolerated a soft diet. Upon discharge, instructions were given to stop taking traditional Chinese herbal medicines, and polyethylene glycol 4000 was prescribed to maintain bowel regularity. IMP is a rare chronic venous disease characterized by mesenteric vein calcification, often associated with the long-term use of Chinese herbal medicines [1]. Diagnosis can be delayed because of the nonspecific presentation [2] [3]. Key diagnostic points include long-term use of traditional Chinese medicine, mesenteric vascular calcification on CT imaging, and colonoscopic findings of diffuse dark-purple discoloration of the mucosa, resembling widespread varicosities, with lesions confined to the colon [4]. Endoscopy_UCTN_Code_CCL_1AD_2AF Article published online: 22 May 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 14 January 2025
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 57 (S 01) , E453-E454
Open AccessA rare etiology of partial intestinal obstruction and sepsis: idiopathic mesenteric phlebosclerosis
A 64-year-old woman presented with abdominal pain and vomiting for 4 days. She had a medical history of long-term use of traditional Chinese medicine prescribed by her family doctor for more than 10 years. Blood biochemistry tests showed an increase in leukocytosis (WBC 17.18 × 109/L, 88% neutrophils) and elevated procalcitonin (76.42 ng/mL), indicating a systemic infection. Notably, noncontrast abdominal CT revealed signs of incomplete bowel obstruction, especially characteristic mesenteric vessel calcification and colonic wall thickening in the cecum ([Fig. 1]). After empirical treatment with broad-spectrum antibiotics (ertapenem and teicoplanin) for suspected sepsis, the patient’s condition improved, procalcitonin levels returned to normal, and the gastrointestinal function was restored. We then performed a routine colonoscopy and found that the confined colonic mucosa had a dark-purple discoloration, similar to widespread varicosities. When the colon is fully inflated, normal mucosa between the dark purple areas corresponding to the submucosal veins could be observed, which, combined with the patient's previous medication history, clinical manifestations, abdominal CT, and colonoscopy, the patient can be clearly diagnosed with IMP ([Fig. 2], [Video 1]). After conservative treatment, the patientʼs abdominal pain and vomiting resolved and she tolerated a soft diet. Upon discharge, instructions were given to stop taking traditional Chinese herbal medicines, and polyethylene glycol 4000 was prescribed to maintain bowel regularity. IMP is a rare chronic venous disease characterized by mesenteric vein calcification, often associated with the long-term use of Chinese herbal medicines [1]. Diagnosis can be delayed because of the nonspecific presentation [2] [3]. Key diagnostic points include long-term use of traditional Chinese medicine, mesenteric vascular calcification on CT imaging, and colonoscopic findings of diffuse dark-purple discoloration of the mucosa, resembling widespread varicosities, with lesions confined to the colon [4]. Endoscopy_UCTN_Code_CCL_1AD_2AF Article published online: 22 May 2025 © 2025. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany
- 13 June 2024
- Published by Wiley in Digestive Endoscopy
- Vol. 36 (8) , 957-958
Novel three‐traction strings device with endoscopic submucosal dissection for the removal of a large rectal sessile serrated adenoma
Watch a video of this article.
- 13 June 2024
- Published by Wiley in Digestive Endoscopy
- Vol. 36 (8) , 957-958
Novel three‐traction strings device with endoscopic submucosal dissection for the removal of a large rectal sessile serrated adenoma
Watch a video of this article.
- Open Access
- 9 January 2024
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 56 (S 01) , E669-E670
A novel strategy for performing endoscopic submucosal dissection for circumferential superficial esophageal neoplastic lesions with kissing traction
Endoscopic submucosal dissection (ESD) is a widely utilized procedure for early esophageal cancer and precancerous lesions. However, it remains technically challenging and time consuming for circumferential lesions. Numerous studies have utilized various techniques for improving the efficacy of ESD in the treatment of esophageal circumferential lesions [1] [2] [3]. Herein, we propose a novel approach for improving ESD for esophageal peripheral lesions, termed the “kissing traction technique” (KT-ESD). Over 3 years, six patients (four male, two female; mean age 62.5 years) with circumferential superficial esophageal neoplastic lesions underwent KT-ESD. Informed consent for the procedure was signed by all patients before the procedure intervention. The steps of KT-ESD were as follows ([Video 1]). 1) Esophageal iodine staining ([Fig. 1] a). 2) Marking the lesion. 3) Marking a circumferential incision on the anal and oral sides of the lesion (0.5 cm away from the lesion). 4) Dissection to reveal the mucosal flap from the oral side of the lesion ([Fig. 1] b). 5) Using two legs of titanium clips to clamp the two kissing mucosal flaps before traction ([Fig. 1] c,d), so that only one traction is needed to pull up the whole lesion. 6) Complete dissection along the submucosa. 7) Injection of triamcinolone acetonide solution on the wound; postoperative oral steroids were administered to prevent stenosis. The length of the lesions ranged from 5.0 to 9.5 cm, with operation times ranging from 55 to 92 minutes ([Table 1]). None of the patients experienced intraoperative or postoperative bleeding or perforation. No recurrence was observed in subsequent follow-up. During the 3–30 months of postoperative follow-up, two of the six patients developed esophageal stenosis; however, the stenosis was successfully relieved following two to three balloon dilation procedures. In conclusion, KT-ESD demonstrated a significant improvement in dissection efficiency for peripheral esophageal lesions, without an increase in complications. Endoscopy_UCTN_Code_TTT_1AO_2AG_3AZ Article published online: 30 July 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 9 January 2024
- Published by Georg Thieme Verlag KG in Endoscopy
- Vol. 56 (S 01) , E669-E670
Open AccessA novel strategy for performing endoscopic submucosal dissection for circumferential superficial esophageal neoplastic lesions with kissing traction
Endoscopic submucosal dissection (ESD) is a widely utilized procedure for early esophageal cancer and precancerous lesions. However, it remains technically challenging and time consuming for circumferential lesions. Numerous studies have utilized various techniques for improving the efficacy of ESD in the treatment of esophageal circumferential lesions [1] [2] [3]. Herein, we propose a novel approach for improving ESD for esophageal peripheral lesions, termed the “kissing traction technique” (KT-ESD). Over 3 years, six patients (four male, two female; mean age 62.5 years) with circumferential superficial esophageal neoplastic lesions underwent KT-ESD. Informed consent for the procedure was signed by all patients before the procedure intervention. The steps of KT-ESD were as follows ([Video 1]). 1) Esophageal iodine staining ([Fig. 1] a). 2) Marking the lesion. 3) Marking a circumferential incision on the anal and oral sides of the lesion (0.5 cm away from the lesion). 4) Dissection to reveal the mucosal flap from the oral side of the lesion ([Fig. 1] b). 5) Using two legs of titanium clips to clamp the two kissing mucosal flaps before traction ([Fig. 1] c,d), so that only one traction is needed to pull up the whole lesion. 6) Complete dissection along the submucosa. 7) Injection of triamcinolone acetonide solution on the wound; postoperative oral steroids were administered to prevent stenosis. The length of the lesions ranged from 5.0 to 9.5 cm, with operation times ranging from 55 to 92 minutes ([Table 1]). None of the patients experienced intraoperative or postoperative bleeding or perforation. No recurrence was observed in subsequent follow-up. During the 3–30 months of postoperative follow-up, two of the six patients developed esophageal stenosis; however, the stenosis was successfully relieved following two to three balloon dilation procedures. In conclusion, KT-ESD demonstrated a significant improvement in dissection efficiency for peripheral esophageal lesions, without an increase in complications. Endoscopy_UCTN_Code_TTT_1AO_2AG_3AZ Article published online: 30 July 2024 © 2024. The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/). Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
- 29 May 2022
- Published by Wiley in Digestive Endoscopy
- Vol. 34 (5) , E107-E108
Switching from the clip‐and‐snare method with a prelooping technique to triangle traction in endoscopic submucosal dissection for treatment of gastroesophageal junction early cancer
- 29 May 2022
- Published by Wiley in Digestive Endoscopy
- Vol. 34 (5) , E107-E108
Switching from the clip‐and‐snare method with a prelooping technique to triangle traction in endoscopic submucosal dissection for treatment of gastroesophageal junction early cancer
- Open Access
- 4 April 2022
- Published by Wiley in Journal of Oncology
- Vol. 2022, 1-9
Comparison of Two Different Accesses Single Orifice Percutaneous Endoscopic Surgery in Diagnosis of Ascites of Unknown Origin: A Retrospective Study
Background. Ascites is a common clinical finding caused by many different diseases, so we developed a technique termed single orifice percutaneous endoscopic surgery (SOPES) which can access peritoneal cavity through the contralateral McBurney’s point or umbilicus to seek the underlying causes. In this study, we describe the initial clinical experience of SOPES and compare the application of two accesses. Methods. This is a retrospective study performed between 2007 and 2018. Patients with ascites of unknown origin who underwent these two kinds of SOPES were included. Main outcomes were measured by diagnostic accuracy, complication rate, procedure time, time till stitches removal, length of hospital stay, and hospital cost. Results. 148 patients successfully undergone SOPES via the contralateral McBurney’s point (IM group, ) or the umbilicus (UM group, ). 63 patients in the IM group and 71 patients in the UM group reached clear diagnosis (90.0% vs. 91.0%, ). The overall complication rate was 5.4%, while the UM group was higher than the IM group (10.3% vs. 0%, ). All complications were resolved after medical treatment, and no mortality resulted from this procedure. The procedure time and the time until stitches removal in the UM group were longer than that in the IM group. There were no significant differences in length of hospital stay and hospital cost between the two groups. Conclusions. SOPES, which combines the strength of minimally invasive single orifice incision and flexible angles of examination and instrumentation, is a newly developed flexible endoscopic surgical modality that provides new important clinical valuable in evaluation of ascites of unknown origin. Moreover, SOPES via the contralateral McBurney’s point was safer than the umbilicus approach.
- 4 April 2022
- Published by Wiley in Journal of Oncology
- Vol. 2022, 1-9
Open AccessComparison of Two Different Accesses Single Orifice Percutaneous Endoscopic Surgery in Diagnosis of Ascites of Unknown Origin: A Retrospective Study
Background. Ascites is a common clinical finding caused by many different diseases, so we developed a technique termed single orifice percutaneous endoscopic surgery (SOPES) which can access peritoneal cavity through the contralateral McBurney’s point or umbilicus to seek the underlying causes. In this study, we describe the initial clinical experience of SOPES and compare the application of two accesses. Methods. This is a retrospective study performed between 2007 and 2018. Patients with ascites of unknown origin who underwent these two kinds of SOPES were included. Main outcomes were measured by diagnostic accuracy, complication rate, procedure time, time till stitches removal, length of hospital stay, and hospital cost. Results. 148 patients successfully undergone SOPES via the contralateral McBurney’s point (IM group, ) or the umbilicus (UM group, ). 63 patients in the IM group and 71 patients in the UM group reached clear diagnosis (90.0% vs. 91.0%, ). The overall complication rate was 5.4%, while the UM group was higher than the IM group (10.3% vs. 0%, ). All complications were resolved after medical treatment, and no mortality resulted from this procedure. The procedure time and the time until stitches removal in the UM group were longer than that in the IM group. There were no significant differences in length of hospital stay and hospital cost between the two groups. Conclusions. SOPES, which combines the strength of minimally invasive single orifice incision and flexible angles of examination and instrumentation, is a newly developed flexible endoscopic surgical modality that provides new important clinical valuable in evaluation of ascites of unknown origin. Moreover, SOPES via the contralateral McBurney’s point was safer than the umbilicus approach.
- Open Access
- 1 January 2021
- Published by Wiley in Canadian Journal of Gastroenterology and Hepatology
- Vol. 2021 (1)
Optimal Timing of Simethicone Supplement for Bowel Preparation: A Prospective Randomized Controlled Trial
Background and Aims. Simethicone (SIM), as an antifoaming agent, has been shown to improve bowel preparation during colonoscopy. However, the optimal timing of SIM addition remained undetermined. We aimed to investigate the optimal timing of SIM addition to polyethylene glycol (PEG) to improve bowel preparation. Methods. Eligible patients were randomly assigned to two groups: the SIM evening group (SIM addition to PEG in the evening of the day prior to colonoscopy) and the SIM morning group (SIM addition to PEG in the morning of colonoscopy). The primary outcome was Bubble Scale (BS). The secondary outcomes were Boston Bowel Preparation Scale (BBPS) and adenoma detection rate (ADR). Results. A total of 419 patients were enrolled in this study. The baseline characteristics of the patients were similar in both groups. No significant differences were observed in terms of BS (8.76 ± 0.90 vs. 8.65 ± 1.16, P = 0.81), ADR (34.1% vs. 30.8%, P = 0.47), Boston Bowel Preparation Scale (BBPS) (8.59 ± 0.94 vs. 8.45 ± 1.00, P = 0.15), and withdrawal time (8.22 ± 2.04 vs. 8.01 ± 2.51, P = 0.094) between the two groups. Moreover, safety and compliance were similar in both groups. However, the SIM evening group was associated with shorter cecal intubation time (3.80 ± 1.81 vs. 4.42 ± 2.03, P < 0.001), higher BS (2.95 ± 0.26 vs. 2.88 ± 0.38, P = 0.04) in the right colon, and diminutive ADR (62.5% vs. 38.6%, P = 0.022) in the right colon, when compared to the SIM evening group. Conclusions. The SIM addition to PEG in the evening of the day prior to colonoscopy can shorten cecal intubation time and improve BS scores and diminutive ADR of the right colon compared with the SIM addition to PEG in the morning of colonoscopy in bowel preparation.
- 1 January 2021
- Published by Wiley in Canadian Journal of Gastroenterology and Hepatology
- Vol. 2021 (1)
Open AccessOptimal Timing of Simethicone Supplement for Bowel Preparation: A Prospective Randomized Controlled Trial
Background and Aims. Simethicone (SIM), as an antifoaming agent, has been shown to improve bowel preparation during colonoscopy. However, the optimal timing of SIM addition remained undetermined. We aimed to investigate the optimal timing of SIM addition to polyethylene glycol (PEG) to improve bowel preparation. Methods. Eligible patients were randomly assigned to two groups: the SIM evening group (SIM addition to PEG in the evening of the day prior to colonoscopy) and the SIM morning group (SIM addition to PEG in the morning of colonoscopy). The primary outcome was Bubble Scale (BS). The secondary outcomes were Boston Bowel Preparation Scale (BBPS) and adenoma detection rate (ADR). Results. A total of 419 patients were enrolled in this study. The baseline characteristics of the patients were similar in both groups. No significant differences were observed in terms of BS (8.76 ± 0.90 vs. 8.65 ± 1.16, P = 0.81), ADR (34.1% vs. 30.8%, P = 0.47), Boston Bowel Preparation Scale (BBPS) (8.59 ± 0.94 vs. 8.45 ± 1.00, P = 0.15), and withdrawal time (8.22 ± 2.04 vs. 8.01 ± 2.51, P = 0.094) between the two groups. Moreover, safety and compliance were similar in both groups. However, the SIM evening group was associated with shorter cecal intubation time (3.80 ± 1.81 vs. 4.42 ± 2.03, P < 0.001), higher BS (2.95 ± 0.26 vs. 2.88 ± 0.38, P = 0.04) in the right colon, and diminutive ADR (62.5% vs. 38.6%, P = 0.022) in the right colon, when compared to the SIM evening group. Conclusions. The SIM addition to PEG in the evening of the day prior to colonoscopy can shorten cecal intubation time and improve BS scores and diminutive ADR of the right colon compared with the SIM addition to PEG in the morning of colonoscopy in bowel preparation.
- Open Access
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1) , 5570731
Colonic Epithelial PHLPP2 Deficiency Promotes Colonic Epithelial Pyroptosis by Activating the NF‐κB Signaling Pathway
Background. Ulcerative colitis (UC) is a chronic inflammatory disease with increasing prevalence worldwide. Barrier defect in intestinal epithelial cells (IECs) is one of the main pathogeneses in UC. Pyroptosis is a programmed lytic cell death and is triggered by inflammatory caspases, while little is known about its role in UC. Methods. Differentially expressed genes (DEGs) were identified by comparing UC patients with healthy controls from the GEO datasets. The candidate genes involved in pyroptosis were obtained, and the underlying molecular mechanism in the progression of UC was explored in vivo and in vitro. Results. Pleckstrin homology domain leucine‐rich repeat protein phosphatase 2 (PHLPP2), a protein phosphatase, was downregulated and involved in regulating inflammation‐induced IEC pyroptosis by modulating the NF‐κB signaling in UC through bioinformatics analysis. Moreover, we demonstrated that PHLPP2 was downregulated in UC patients and UC mice. Besides, we found that PHLPP2 depletion activated the NF‐κB signaling and increased the expressions of caspase‐1 P20, Gasdermin N, IL‐18, and IL‐1β contributing to IEC pyroptosis and inflammation in UC mice. Furthermore, we found that PHLPP2-/- mice developed hypersensitivity to dextran sulfate sodium (DSS) treatment toward colitis showing activated NF‐κB signaling and dramatically induced expressions of caspase‐1 P20, Gasdermin N, IL‐18, and IL‐1β. Mechanically, this inflammation‐induced downregulation of PHLPP2 was alleviated by an NF‐κB signaling inhibitor in intestinal organoids of PHLPP2-/- mice and fetal colonic cells. Conclusions. PHLPP2 downexpression activated the NF‐κB signaling and promoted the IEC pyroptosis, leading to UC progression. Therefore, PHLPP2 might be an attractive candidate therapeutic target for UC.
- 1 January 2021
- Published by Wiley in Oxidative Medicine and Cellular Longevity
- Vol. 2021 (1) , 5570731
Open AccessColonic Epithelial PHLPP2 Deficiency Promotes Colonic Epithelial Pyroptosis by Activating the NF‐κB Signaling Pathway
Background. Ulcerative colitis (UC) is a chronic inflammatory disease with increasing prevalence worldwide. Barrier defect in intestinal epithelial cells (IECs) is one of the main pathogeneses in UC. Pyroptosis is a programmed lytic cell death and is triggered by inflammatory caspases, while little is known about its role in UC. Methods. Differentially expressed genes (DEGs) were identified by comparing UC patients with healthy controls from the GEO datasets. The candidate genes involved in pyroptosis were obtained, and the underlying molecular mechanism in the progression of UC was explored in vivo and in vitro. Results. Pleckstrin homology domain leucine‐rich repeat protein phosphatase 2 (PHLPP2), a protein phosphatase, was downregulated and involved in regulating inflammation‐induced IEC pyroptosis by modulating the NF‐κB signaling in UC through bioinformatics analysis. Moreover, we demonstrated that PHLPP2 was downregulated in UC patients and UC mice. Besides, we found that PHLPP2 depletion activated the NF‐κB signaling and increased the expressions of caspase‐1 P20, Gasdermin N, IL‐18, and IL‐1β contributing to IEC pyroptosis and inflammation in UC mice. Furthermore, we found that PHLPP2-/- mice developed hypersensitivity to dextran sulfate sodium (DSS) treatment toward colitis showing activated NF‐κB signaling and dramatically induced expressions of caspase‐1 P20, Gasdermin N, IL‐18, and IL‐1β. Mechanically, this inflammation‐induced downregulation of PHLPP2 was alleviated by an NF‐κB signaling inhibitor in intestinal organoids of PHLPP2-/- mice and fetal colonic cells. Conclusions. PHLPP2 downexpression activated the NF‐κB signaling and promoted the IEC pyroptosis, leading to UC progression. Therefore, PHLPP2 might be an attractive candidate therapeutic target for UC.